LEGN — LEGEND BIOTECH CORP

Ownership history in AM Squared Ltd  ·  1 quarter on record

This page tracks every 13F SEC filing in which AM Squared Ltd reported a position in LEGEND BIOTECH CORP (LEGN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.18% (2024 Q2)
Avg. % of fund
0.18%
First filed
2024 Q2
Last filed
2024 Q2
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q2 INITIATED 1,600 — — 0.18% $71K —
% of Fund (quarterly)    LEGN price (monthly, adj. close)

Other funds also holding LEGN

As of 2025 Q4 — sorted by position size

IvyRock Asset Management (HK) Ltd 3Y 9.22% MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 3Y 7Y 6.31% HHLR ADVISORS, LTD. 3Y 7Y 4.19% JOHNSON & JOHNSON 3Y 3.19% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 2.94% Eagle Health Investments LP 3Y 1.95% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.65% ABS Direct Equity Fund LLC 1.22% BRAIDWELL LP 3Y 0.9% Triata Capital Ltd 0.67%
← Back to AM Squared Ltd Holdings